BMY

Bristol-Myers Squibb Company · NYSE · Healthcare · USD · 10-K for 2025, filed 2026-02-11

Figures on this page computed 2026-11-08 12:24 UTC

Last close

62.14USD

Market data, 2026-11-06

Except where said otherwise: 10-K for 2025, filed 2026-02-11

  • 17.9xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Fiscal year
    2025
    Accession
    0000014272-26-000004
    Reported in
    USD
    • computed
    • 10-K for 2025, filed 2026-02-11

    The filing itself

  • 15.3%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Fiscal year
    2025
    Accession
    0000014272-26-000004
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-11
    • 10-K for 2025, filed 2026-02-11
    • 10-K for 2025, filed 2026-02-11
    • 10-Q for 2025, filed 2026-10-29
    • 10-K for 2025, filed 2026-02-11
    • 10-Q for 2025, filed 2026-10-29

    The filing itself

  • 14.6%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0000014272-26-000004
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-11
    • 10-K for 2025, filed 2026-02-11

    The filing itself

  • 26.6%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Fiscal year
    2025
    Accession
    0000014272-26-000004
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-11
    • 10-K for 2025, filed 2026-02-11

    The filing itself

  • 2.55Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Fiscal year
    2025
    Accession
    0000014272-26-000004
    Reported in
    USD
    • 10-K for 2025, filed 2026-02-11
    • 10-Q for 2025, filed 2026-10-29

    The filing itself

  • 4.1%Dividend yield
    Source
    computed
    Taken on
    2026-11-07
    Reported in
    USD
    • computed
    • computed
    • computed
    • computed
    • computed
    • Computed from the filing for 2025, filed 2026-02-11

Where the price sits

lens 6 of 9

Its multiple of earnings

17.9x
Lowest drawn 0x17.9xHighest drawn 32.3x
This company is at 17.9x earnings, its sector's middle at 26.9x and the market's at 19.9x.
  • Where it is now17.9x
  • Its sector's middle26.9x
  • The market's middle19.9x

Its own year, in the price it trades at

62.1
Year low 42.662.1Year high 68.1
Its last close is 62.1, inside a year that ran from 42.6 to 68.1.

Market data, 2026-11-06

Its price against earnings, set beside its own year, its sector and the market. A low multiple is cheap or it is broken, and this page does not claim to know which.

Its price against earnings, set beside its own year, its sector and the market. A low multiple is cheap or it is broken, and this page does not claim to know which.

Every figure in this lens

  • Price against earnings17.9x10-K for 2025, filed 2026-02-11
    Source
    filed
    Statement
    income
    Fiscal year
    2025
    Accession
    0000014272-26-000004
    Reported in
    USD

    The filing itself

  • Last close62.1Market data, 2026-11-06
    Source
    market
    Taken on
    2026-11-06
    Reported in
    USD

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.